KMK
NEUTRALKromek Director Boosts Stake with Share Purchase
The scientific instruments company Kromek has announced that one of its non-executive directors has purchased additional shares in the company.
Kromek Group
6.90GBX
2.22%
Market Cap
45.20M
Volume
1.17M
52% of avg
P/E Ratio
-12.55
EPS (TTM)
-0.55
Beta
0.84
Day Range
6.70p - 6.90p
52 Week Range
4.30p6.90p9.50p
6.90p
Upcoming Events
KMK
NEUTRALKromek Group Announces Grant of Options and PDMR Dealings
The technology company has granted options to its directors and announced PDMR dealings.
KMK
VERY GOODKromek Group Delivers Strong First Half Performance
The technology company reports strong first half performance, with significant improvements in profitability and revenue growth.
KMK
NEUTRALKromek Announces AGM and Board Changes
The technology company announces its upcoming annual general meeting and changes to its board of directors, including the retirement of two non-executive directors and the appointment of a new non-executive director.
KMK
GOODKromek Group Reports First-Ever Profit, Exceeding Market Expectations
This radiation and bio-detection technology developer reported its first-ever profit, significantly exceeding market expectations. Revenue surged 37%, driven by a landmark agreement with Siemens Healthineers.
KMK
GOODKromek Secures New Biosecurity Contract from UK MoD
The technology company has secured a new biosecurity contract from the UK Ministry of Defence and received additional CBRN detection orders from global customers, providing increased visibility on future revenue.
KMK
GOODKromek Receives $5m Under Siemens Healthineers Agreement
The technology company has received a $5m payment under its agreement with a major healthcare partner, strengthening its balance sheet and providing a foundation for sustainable growth.
KMK
GOODKromek Wins £1.7m Contract Under UK Government Framework
The technology company has secured a £1.7m contract under the UK Government's Radiological Nuclear Detection Framework, affirming its leadership in the CBRN detection sector.
KMK
NEUTRALKromek Hosts Capital Markets Day Presentation
The technology company hosts a presentation for investors, providing an overview of its business and operations.
KMK
NEUTRALKromek Hosts Capital Markets Day to Outline Growth Strategy
The scientific instruments company is hosting a capital markets day to discuss its growth strategy, including plans to scale the business to achieve revenues over £60m and a 30% EBITDA margin.